1. Home
  2. NVAX vs NAC Comparison

NVAX vs NAC Comparison

Compare NVAX & NAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • NAC
  • Stock Information
  • Founded
  • NVAX 1987
  • NAC 1998
  • Country
  • NVAX United States
  • NAC France
  • Employees
  • NVAX N/A
  • NAC N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • NAC Investment Managers
  • Sector
  • NVAX Health Care
  • NAC Finance
  • Exchange
  • NVAX Nasdaq
  • NAC Nasdaq
  • Market Cap
  • NVAX 1.3B
  • NAC 1.6B
  • IPO Year
  • NVAX 1995
  • NAC N/A
  • Fundamental
  • Price
  • NVAX $8.64
  • NAC $11.41
  • Analyst Decision
  • NVAX Buy
  • NAC
  • Analyst Count
  • NVAX 7
  • NAC 0
  • Target Price
  • NVAX $14.29
  • NAC N/A
  • AVG Volume (30 Days)
  • NVAX 6.9M
  • NAC 307.3K
  • Earning Date
  • NVAX 11-11-2025
  • NAC 01-01-0001
  • Dividend Yield
  • NVAX N/A
  • NAC 4.33%
  • EPS Growth
  • NVAX N/A
  • NAC N/A
  • EPS
  • NVAX 2.54
  • NAC N/A
  • Revenue
  • NVAX $1,078,718,000.00
  • NAC N/A
  • Revenue This Year
  • NVAX $61.69
  • NAC N/A
  • Revenue Next Year
  • NVAX N/A
  • NAC N/A
  • P/E Ratio
  • NVAX $3.18
  • NAC N/A
  • Revenue Growth
  • NVAX 9.22
  • NAC N/A
  • 52 Week Low
  • NVAX $5.01
  • NAC $9.32
  • 52 Week High
  • NVAX $15.22
  • NAC $11.21
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 60.46
  • NAC 57.24
  • Support Level
  • NVAX $7.83
  • NAC $11.13
  • Resistance Level
  • NVAX $8.31
  • NAC $11.64
  • Average True Range (ATR)
  • NVAX 0.37
  • NAC 0.08
  • MACD
  • NVAX 0.05
  • NAC 0.01
  • Stochastic Oscillator
  • NVAX 99.49
  • NAC 53.92

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About NAC Nuveen California Quality Municipal Income Fund

Nuveen California Quality Municipal Income Fund is a diversified closed-end management investment company. Its objective is to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal and California state income taxes. It invests majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: